Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN010 HFA vs Symbicort Bioequivalence Study
NCT04494321Phase 1Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of budesonide + formoterol in asthma and chronic obstructive pulmonary disease (COPD), sponsored by Intech Biopharm Corporation. Started Jun 2017; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04494321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494321.